Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis

Nephrology

Volumn 11, Issue 3, 2006, Pages 192-196

  Necla, Buyan ^a,c   Aysun, Bideci ^a   Ozan, Ozkaya ^b   Erol, Ortac ^b   Sevcan, Bakkaloglu ^a   Sevim, Gonen ^a   Harun, Peru ^a   Oǧuz, Soylemezoglu ^a   Peyami, Cinaz ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c ORAN   (Turkey)

Author keywords

Chronic renal failure; Insulin resistance; Leptin; Resistin

Indexed keywords

LEPTIN; RESISTIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIALYSIS; GLUCOSE METABOLISM; HEMODIALYSIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE; HUMANS; LEPTIN; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RESISTIN;

EID: 33744822196     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00570.x     Document Type: Article

References (30)

1. Stenvinkel P, Pecoits-Filho R, Lindholm B. Leptin, ghrelin, and proinflammatory cytokines: Compounds with nutritional impact in chronic kidney disease? Adv. Ren. Replace. Ther. 2003 10 : 332 45.
2. Arkouche W, Juillard L, Delawari E et al. Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 1999 34 : 839 44.
3. Stenvinkel P, Lönnqvist F, Schalling M. Molecular studies of leptin: Implications for renal disease. Nephrol. Dial. Transplant. 1999 14 : 1103 12.
4. Gimeno RE, Klaman LD. Adipose tissue as an active endocrine organ: Recent advances. Curr. Opin. Pharmacol. 2005 5 : 122 8.
5. Dötsch J, Nüsken K, Schroth M, Rascher W, Meissner U. Alterations of leptin and ghrelin serum concentrations in renal disease: Simple epiphenomena? Pediatr. Nephrol. 2005 20 : 701 6.
6. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am. J. Kidney Dis. 2005 39 : 1 11.
7. Diez JJ, Iglesias P, Fernandez-Reyes MJ et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin. Endocrinol. 2005 62 : 242 9.
8. Kielstein JT, Becker B, Graf S, Brabat G, Haller H, Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am. J. Kidney Dis. 2003 42 : 62 6.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 7 : 412 19.
10. Katz A, Sridhar SN, Albert P, Sumner AE, Quon MJ. Quantitative Insulin-Sensitivity Check Index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 2000 85 : 2402 10.
11. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr. Clin. North Am. 1987 34 : 571 90.
12. Nishizawa Y, Shoji T, Emoto M et al. Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: Another form of metabolic syndrome. Semin. Nephrol. 2004 24 : 423 5.
13. Mak RH, Haycock GB, Chantler C. Glucose intolerance in children with chronic renal failure. Kidney Int. 1983 15 : S22 6.
14. Becker B, Kronenberg F, Kielstein JT et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study. J. Am. Soc. Nephrol. 2005 16 : 1091 8.
15. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: The role of adipokines. J. Ren. Nutr. 2005 15 : 131 6.
16. Chan DC, Watts GF, Ng TW et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin. Chem. 2005 51 : 578 85. [Epub ahead of print].
17. Meier U, Gressner AM. Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 2004 50 : 1511 24.
18. Verma S, Li SH, Wang CH et al. Resistin promotes endothelial cell activation: Further evidence of adipokin endothelial interaction. Circulation 2003 12 : 736 40.
19. Yudkin JS, Eringa E, Stehouwer CD. 'Vasocrine' signalling from perivascular fat: A mechanism linking insulin resistance to vascular disease. Lancet 2005 365 : 1817 20.
20. Lahlou N, Issad T, Lebouc Y et al. Mutations in the human leptin and leptin receptor genes as models of serum leptin receptor regulation. Diabetes 2002 51 : 1980 85.
21. Pecoits-Filho R, Nordfors L, Heimburger O et al. Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J. Clin. Invest. 2002 32 : 811 17.
22. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J. Am. Soc. Nephrol. 2000 11 : 1303 9.
23. Kagan A, Haran N, Leschinsky L, Shuali N, Rapoport J. Leptin in CAPD patients: Serum concentrations and peritoneal loss. Nephrol. Dial. Transplant. 1999 14 : 400 405.
24. Daschner M, Tonshoff B, Blum WF et al. Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J. Am. Soc. Nephrol. 1998 9 : 1074 9.
25. Besbas N, Ozaltin F, Coskun T et al. Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr. Nephrol. 2003 18 : 1255 9.
26. Besbas N, Ozdemir S, Saatci U et al. Nutritional assessment of children on haemodialysis: Value of IGF-I, TNF-alpha and IL-1beta. Nephrol. Dial. Transplant. 1998 13 : 1484 8.
27. Clark RG. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure. Pediatr. Nephrol. 2005 20 : 290 94.
28. Lehrke M, Reilly MP. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004 1 : 161 8.
29. Chen YH, Hung PF, Kao YH. IGF-I downregulates resistin gene expression and protein secretion. Am. J. Physiol. Endocrinol. Metab. 2005 288 : E1019 27.
30. Ranke MB. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol. Metab. 2005 16 : 190 97.